Artivion, Inc. (AORT)
21.78
-0.09
(-0.41%)
USD |
NYSE |
Oct 16, 16:00
21.69
-0.09
(-0.41%)
After-Hours: 20:00
Artivion Cash from Investing (Quarterly) : -129.41M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -129.41M |
| March 31, 2026 | -10.50M |
| December 31, 2025 | -30.51M |
| September 30, 2025 | -4.609M |
| June 30, 2025 | -3.287M |
| March 31, 2025 | -3.638M |
| December 31, 2024 | -11.42M |
| September 30, 2024 | -10.64M |
| June 30, 2024 | -2.513M |
| March 31, 2024 | -3.611M |
| December 31, 2023 | -2.669M |
| September 30, 2023 | -2.068M |
| June 30, 2023 | 7.078M |
| March 31, 2023 | -2.843M |
| December 31, 2022 | -2.668M |
| September 30, 2022 | -3.053M |
| June 30, 2022 | -2.286M |
| March 31, 2022 | -2.708M |
| December 31, 2021 | -2.812M |
| September 30, 2021 | 15.52M |
| June 30, 2021 | -6.234M |
| March 31, 2021 | -0.81M |
| December 31, 2020 | -2.346M |
| September 30, 2020 | -66.30M |
| June 30, 2020 | -1.578M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.903M |
| December 31, 2019 | -3.19M |
| September 30, 2019 | -17.11M |
| June 30, 2019 | -2.219M |
| March 31, 2019 | -1.427M |
| December 31, 2018 | -1.718M |
| September 30, 2018 | -1.366M |
| June 30, 2018 | -1.512M |
| March 31, 2018 | -2.119M |
| December 31, 2017 | -166.35M |
| September 30, 2017 | -1.08M |
| June 30, 2017 | -2.234M |
| March 31, 2017 | -1.325M |
| December 31, 2016 | -2.748M |
| September 30, 2016 | -1.945M |
| June 30, 2016 | -2.006M |
| March 31, 2016 | -67.16M |
| December 31, 2015 | -1.683M |
| September 30, 2015 | -1.015M |
| June 30, 2015 | -0.238M |
| March 31, 2015 | -1.55M |
| December 31, 2014 | -0.546M |
| September 30, 2014 | -1.013M |
| June 30, 2014 | -2.115M |
| March 31, 2014 | -1.679M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | -22.72M |
| Glaukos Corp. | -5.306M |
| TransMedics Group, Inc. | -7.092M |
| Embecta Corp. | -129.50M |
| Abbott Laboratories | -673.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.266M |
| Cash from Financing (Quarterly) | 152.39M |
| Free Cash Flow | -9.157M |
| Free Cash Flow Per Share (Quarterly) | -0.2475 |
| Free Cash Flow to Equity (Quarterly) | -161.82M |
| Free Cash Flow to Firm (Quarterly) | -3.638M |
| Free Cash Flow Yield | -0.86% |